Pientzehuang proposes $1.1bn dividend amid growth
Zhangzhou Pientzehuang Pharmaceutical (SSE:600436) announced plans to distribute a cash dividend of $CNY 1.1 billion, or CNY 1.82 per share, based on the company's total share capital as of the record date. The proposal, pending shareholder approval, represents 36.88% of the company's 2024 net profit attributable to shareholders. Inclusive of an interim dividend already distributed, Pientzehuang's total 2024 cash distribution reaches CNY 1.79 billion, or 60.19% of net profits.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Zhangzhou Pientzehuang Pharmaceutical publishes news
Free account required • Unsubscribe anytime